TABLE 3A.
No Treatment | Vanco | Metro | Both | Both+Rifa | N | P Value† | |
---|---|---|---|---|---|---|---|
CDI severity | |||||||
Moderate | 1 (2) | 11 (24) | 20 (44) | 13 (29) | 0 (0) | 45 | .40 |
Severe | 0 (0) | 1 (13) | 3 (38) | 4 (50) | 0 (0) | 8 | |
Severe-complicated | 0 (0) | 0 (0) | 4 (40) | 6 (60) | 0 (0) | 10 | |
Subsequent CDI | 63 | .54 | |||||
No | 1 (2) | 7 (11) | 21 (33) | 15 (24) | 0 (0) | ||
Yes | 0 (0) | 5 (8) | 6 (10) | 8 (13) | 0 (0) | ||
Recurrent CDI | 63 | .63 | |||||
No | 1 (2) | 11 (17) | 24 (38) | 18 (29) | 0 (0) | ||
Yes | 0 (0) | 1 (2) | 3 (5) | 5 (8) | 0 (0) | ||
CDI-related hospitalization | 63 | .20 | |||||
No | 1 (2) | 10 (16) | 24 (38) | 23 (37) | 0 (0) | ||
Yes | 0 (0) | 2 (3) | 3 (5) | 0 (0) | 0 (0) | ||
IBD exacerbation | 63 | .38 | |||||
No | 1 (2) | 7 (11) | 12 (19) | 8 (13) | 0 (0) | ||
Yes | 0 (0) | 5 (8) | 15 (24) | 15 (24) | 0 (0) | ||
Colon Surgery | 63 | .11 | |||||
No | 1 (2) | 8 (13) | 23 (37) | 13 (21) | 0 (0) | ||
Yes | 0 (0) | 4 (6) | 4 (6) | 10 (16) | 0 (0) |
Abbreviations: both, vancomycin plus metronidazole; both+rifa, vancomycin plus metronidazole plus rifaximin; metro, metronidazole only; vanco, vancomycin only.
*Data are presented as No. (%).
†Fisher exact test.